Alexis Rompré-Brodeur, MD, a urologic oncologist at McGill University discusses germline testing in patients with renal cell carcinoma. Rompré-Brodeur presented the study, “Germline testing in renal cell carcinoma: can enrichment features help predict germline alterations?” at the 2022 AUA Annual Meeting.
Vobramitamab duocarmazine continues to show promise in mCRPC
May 10th 2024Updated data from the phase 2 TAMARCK study continued to show safety and preliminary efficacy with the B7-H3–targeting antibody-drug conjugate vobramitamab duocarmazine in patients with metastatic castration-resistant prostate cancer.